PASADENA, Texas–(BUSINESS WIRE)–Eurofins J3 Resources, part of Eurofins Built Environment Testing US, is proud to announce it has been granted AIHA LAP, LLC accreditation as part of a National expansion program of Industrial Hygiene credentials. Eurofins J3 Resources’ industrial hygiene service offering to Texas, Louisiana and Gulf Coast based refineries and chemical plants has been … [Read more…]

PORTLAND, Ore.–(BUSINESS WIRE)–Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new clinical pharmacology data at the Endocrine Society (ENDO) 2022 Annual Conference on its candidate, SPI-62, an HSD-1 inhibitor. Sparrow will present the data during an in-person … [Read more…]

— WU-NK-101 exhibited enhanced metabolic flexibility and resistance to tumor microenvironment (TME) immunosuppression relative to conventional natural killer (NK) cells — — WU-NK-101 demonstrated robust anti-tumor activity in vitro and in vivo in preclinical models of acute myeloid leukemia (AML) — — Data support the development of WU-NK-101 for AML and solid tumor indications — … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Partnering Terms and Agreements 2015-2022” report has been added to ResearchAndMarkets.com’s offering. The Global Drug Delivery Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the Drug Delivery partnering deals and agreements entered into by the worlds leading healthcare companies. One of the key highlights of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Diagnostics Partnering Terms and Agreements 2015-2022” report has been added to ResearchAndMarkets.com’s offering. The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,200 Diagnostics deals. The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering … [Read more…]

BETHESDA, Md.–(BUSINESS WIRE)–Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share, announced today that its Board of Directors (“Board”) has declared the Company’s 2022 second … [Read more…]

New publication reveals how a keystone strain exerts potential to impact a spectrum of health outcomes through immune and metabolic regulation SAN FRANCISCO–(BUSINESS WIRE)–Pendulum Therapeutics, the biotech company pioneering the next frontier of health through its microbiome-targeted products, today announced the release of its whitepaper, An In-Depth Profile of the Gut Commensal Akkermansia muciniphila, a … [Read more…]

Clinical data and patient-reported outcomes across extensive clinical development program for zanubrutinib (BRUKINSA®) reinforce its potential across B-cell malignancies Long-term safety and efficacy results from the Phase 3 ASPEN trial of zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia Oral presentation for the Phase 2 ROSEWOOD trial of zanubrutinib plus obinutuzumab in follicular lymphoma New … [Read more…]

TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it will be presenting at Gravitas Securities Inc.’s (“Gravitas”) 3rd Los Angeles Summit, which will be taking place at the Beverly Hills Hotel from June 21st to June 24th, 2022, in Beverly Hills, California. Gravitas’ 3rd Los Angeles … [Read more…]

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today a post-hoc analysis from the Zimura® (avacincaptad pegol) GATHER1 clinical trial which explored enhanced Optical Coherence Tomography (OCT) image analysis to examine the effect of Zimura on change in Ellipsoid Zone (EZ) integrity and growth of OCT-measured geographic atrophy (GA), and to examine the correlation between … [Read more…]